Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 22,170 shares at $54.49 ($1.2M) on 2020-05-08, disclosed to the SEC on 2020-05-12.
Open-market sale of $1.2M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.53 | 730 | $38K | 3.2% |
| 2 | $53.49 | 5,920 | $317K | 26.5% |
| 3 | $53.49 | 5,920 | $317K | 26.5% |
| 4 | $54.49 | 4,750 | $259K | 21.7% |
| 5 | $54.49 | 4,750 | $259K | 21.7% |
| 6 | $55.16 | 100 |
| $6K |
| 0.5% |
| Total | $53.89 avg | 22,170 | $1.2M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |
| TPTX | SELL | 2020-04-24 | $1.5M | — | Filing → |